The Society of Laboratory Automation and Screening (SLAS) has named the 12 corporations chosen to take part in its Innovation AveNEW program on the SLAS Europe 2026 Conference and Exhibition, scheduled for May 19–21 in Vienna, Austria.
Innovation AveNEW is SLAS’s established startup showcase program, designed to join rising life sciences discovery and know-how corporations with buying influencers and decision-makers from greater than 40 international locations. The program covers exhibition charges, journey, and lodging for one firm consultant, and supplies entry to enterprise consulting, mentorship, and unique promotional alternatives. Selected corporations are additionally invited to submit a scientific manuscript to SLAS Discovery or SLAS Technology, SLAS’s peer-reviewed, Gold open-access journals revealed by Elsevier.
The 2026 Cohort
The 12 corporations chosen for Innovation AveNEW at SLAS Europe 2026 symbolize six international locations throughout Europe, North America, and Australia:
-
8-BOT Robotics (Germany)
-
Chemetrian (USA)
-
Culturon Pty Ltd (Australia)
-
DaltonTx (United Kingdom)
-
The Ensynble, Inc. (USA)
-
linkdlab GmbH (Germany)
-
Lutece Dynamics (France)
-
PartitionBio Ltd (United Kingdom)
-
Scalables (USA)
-
Sync Biosystems (Netherlands)
-
Syntopia (France)
-
Trince (Belgium)
Applicants are evaluated by the Innovation AveNEW panel on technical benefit and business feasibility, with standards together with the energy of the science and know-how, startup standing, administration workforce, readability of imaginative and prescient and market alternative, and potential affect on the sphere of laboratory automation and know-how.
Ignite Award Up for Grabs
Each collaborating firm can also be eligible to compete for the SLAS Ignite Award, with the winner introduced on the convention and receiving €5,000.
At SLAS2026 International Conference and Exhibition earlier this 12 months, XDemics took residence the Ignite Award for its work in cell tradition know-how. “Winning the Ignite Award was an incredible honor and validation of the mission XDemics has been on to provide limitless cell culture to power breakthrough science and medicine,” says Colin Cook, co-founder and chief know-how officer of XDemics, in a launch. “The judges gave us very actionable feedback on go-to-market strategy that we are implementing.”
Cook additionally highlighted the worth of the broader program expertise. “There was such a buzz on Innovation AveNEW and a constant flux of prospective customers, executives, researchers coming by to talk shop and see what was new. Many strong connections were made that are going to transform our business and marketing strategy in the HTS space,” he says in a launch.
Supporting the Next Generation of Lab Tech
SLAS chief govt officer Vicki Loise framed this system as central to the group’s broader mission. “SLAS has always prioritized providing life sciences technology start-ups with the invaluable market access, user feedback, and business counsel to grow and scale their business,” says Loise in a launch. “We’re honored to welcome a new cohort of Innovation AveNEW startup companies shaping the future of life sciences discovery and technology to our European conference and exhibition in Vienna.”
For laboratory professionals monitoring rising enabling applied sciences, Innovation AveNEW presents a concentrated take a look at the startups working to advance automation, screening, and discovery workflows throughout the trade.
ID 94965958 © Pixelklex | Dreamstime.com
Related Reading:
(*12*)